» Articles » PMID: 37733152

The Effect of Maternal Adverse Childhood Experiences (ACEs) on Substance Use During Pregnancy

Overview
Specialty Health Services
Date 2023 Sep 21
PMID 37733152
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To analyze adverse childhood experiences (ACEs) among mothers of newborns referred to a hospital's child protection team (CPT) for suspected substance exposure. Researchers hypothesized that a higher prevalence of these mothers have ≥ 4 ACEs than female counterparts in the general population. The study team also explored whether associations existed between type of maternal ACEs and substance use in pregnancy.

Methods: Retrospective review of infant referrals to the CPT in the 3 years after adding an ACEs questionnaire to the consultation process. Bivariate analyses and multivariate logistic regression models examined associations between prenatal substance use and maternal ACEs prevalence, controlling for demographics.

Results: Data from 222 infants (four sets of twins) and 218 mothers were analyzed. Half (50.0%) the infants had withdrawal symptoms. Most (67.0%) women had positive toxicology screens, while 85.0% reported prenatal substance use. Half (50.9%) the mothers reported ≥ 4 ACEs and these individuals had significantly higher odds of cannabinoid use [adjusted odds ratio (aOR), 3.7; 95%CI 2.0, 6.9, p < 0.001) than those with < 4 ACEs. A significant association was found between substance use and ACEs in the household challenges category (p = 0.03), especially parental separation/divorce (p < 0.001).

Conclusions For Practice: As hypothesized, a higher prevalence of mothers referred to the CPT had ≥ 4 ACEs than women in the general population (50.9% vs. 15.2%), and a large proportion had used substances while pregnant. Routine prenatal ACEs screening and universal, nonpunitive toxicology testing of infants and mothers at birth may provide opportunities for intervention while reducing the transgenerational impact of ACEs.

References
1.
Lavista Ferres J, Anderson T, Johnston R, Ramirez J, Mitchell E . Distinct Populations of Sudden Unexpected Infant Death Based on Age. Pediatrics. 2019; 145(1). PMC: 6939839. DOI: 10.1542/peds.2019-1637. View

2.
Austin A, Naumann R, Simmons E . Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy. JAMA Pediatr. 2022; 176(11):1123-1130. PMC: 9486638. DOI: 10.1001/jamapediatrics.2022.3396. View

3.
Azofeifa A, Mattson M, Schauer G, McAfee T, Grant A, Lyerla R . National Estimates of Marijuana Use and Related Indicators - National Survey on Drug Use and Health, United States, 2002-2014. MMWR Surveill Summ. 2016; 65(11):1-28. DOI: 10.15585/mmwr.ss6511a1. View

4.
Batty G, Der G, Deary I . Effect of maternal smoking during pregnancy on offspring's cognitive ability: empirical evidence for complete confounding in the US national longitudinal survey of youth. Pediatrics. 2006; 118(3):943-50. DOI: 10.1542/peds.2006-0168. View

5.
Brown Q, Sarvet A, Shmulewitz D, Martins S, Wall M, Hasin D . Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002-2014. JAMA. 2016; 317(2):207-209. PMC: 5595220. DOI: 10.1001/jama.2016.17383. View